ibopamine has been researched along with Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felder, RA; Jose, PA; Zeng, C | 1 |
| Girbes, AR; Smit, AJ; van Veldhuisen, DJ | 1 |
| Ambrosi, B; Ardeleani, G; Ferraris, P; Morganti, A; Quorso, P; Sala, C; Venegoni, P; Zanchetti, A | 1 |
1 review(s) available for ibopamine and Hypertension
| Article | Year |
|---|---|
A new approach for treatment of hypertension: modifying D1 dopamine receptor function.
Topics: Antihypertensive Agents; Deoxyepinephrine; Dopamine; Dopamine Agonists; Fenoldopam; G-Protein-Coupled Receptor Kinase 4; GTP-Binding Proteins; Humans; Hypertension; Protein Serine-Threonine Kinases; Receptors, Dopamine D1; Renin-Angiotensin System | 2006 |
2 other study(ies) available for ibopamine and Hypertension
| Article | Year |
|---|---|
Dopamine agonists, a new perspective in cardiovascular therapy?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic | 1991 |
Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension.
Topics: Aldosterone; Atrial Natriuretic Factor; Deoxyepinephrine; Dopamine; Humans; Hypertension; Metoclopramide; Prolactin | 1988 |